Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Long Ye

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Autophagy|February 27, 2019
TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradationHua Wu, Xing-Xing Lu, Jing-Ru Wang, et al.
Oncogene|January 21, 2022
Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt signalingXiao-Shun He, Wen-Long Ye, Yu-Juan Zhang, et al.
Cell Chemical Biology|June 24, 2023
TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2Yu-Xuan Liu, Shan Wan, Xiao-Qin Yang, et al.
Cancer Research|March 12, 2024
SPARC Stabilizes ApoE to Induce Cholesterol-Dependent Invasion and Sorafenib Resistance in Hepatocellular CarcinomaShan Wan, Quan-Yao He, Yun Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2024
TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancerWen-Long Ye, Long Huang, Xiao-Qin Yang, et al.
Cell Reports|January 21, 2024
Histone lactylation inhibits RARγ expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signalingXiu-Ming Li, Yun Yang, Fu-Quan Jiang, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Autophagy|February 27, 2019
TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradationHua Wu, Xing-Xing Lu, Jing-Ru Wang, et al.
Oncogene|January 21, 2022
Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt signalingXiao-Shun He, Wen-Long Ye, Yu-Juan Zhang, et al.
Cell Chemical Biology|June 24, 2023
TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2Yu-Xuan Liu, Shan Wan, Xiao-Qin Yang, et al.
Cancer Research|March 12, 2024
SPARC Stabilizes ApoE to Induce Cholesterol-Dependent Invasion and Sorafenib Resistance in Hepatocellular CarcinomaShan Wan, Quan-Yao He, Yun Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2024
TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancerWen-Long Ye, Long Huang, Xiao-Qin Yang, et al.
Cell Reports|January 21, 2024
Histone lactylation inhibits RARγ expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signalingXiu-Ming Li, Yun Yang, Fu-Quan Jiang, et al.
Pageof 2